T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Immunopathology: Evaluation from Discovery to Safety Assessment |
|
Enduring |
|
$25.00 |
HESI Human health and Safety |
|
Enduring |
|
$0.00 |
Regulatory guidance: Introduction |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Animal models and species differences (immune system) |
|
Enduring |
|
$25.00 |
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
Basic immunology: complement and hypersensitivities |
|
Enduring |
|
$25.00 |
Definition, history and application of immunosafety in drug development |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
An Introduction to Immuno-Safety Science |
|
Enduring |
|
$350.00 |
Diversity of immune responses (impact of age, sex, pregnancy, co-morbidities, etc.) |
|
Enduring |
|
$25.00 |
Immunophenotyping |
|
Enduring |
|
$25.00 |
Safety Considerations for Oligonucleotides |
|
Enduring |
|
$25.00 |